{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:09:42Z","timestamp":1775693382118,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015160","name":"Hologic Inc Diagnostic Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jcv.2024.105734","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:39:37Z","timestamp":1727969977000},"page":"105734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["High-risk HPV mRNA testing on self-samples offered to those who do not attend for organised cervical screening \u2013 real world data from the Dumfries and Galloway region in Scotland"],"prefix":"10.1016","volume":"175","author":[{"given":"William","family":"Forson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Elasifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linzi","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-3928","authenticated-orcid":false,"given":"Kate","family":"Cuschieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2024.105734_bib0001","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2024.105734_bib0002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3399\/bjgp22X720197","article-title":"Cervical screening: The evolving landscape","volume":"72","author":"Davies-Oliveira","year":"2022","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.jcv.2024.105734_bib0003","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.27790","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening","volume":"132","author":"Snijders","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2024.105734_bib0004","doi-asserted-by":"crossref","first-page":"e80905","DOI":"10.7554\/eLife.80905","article-title":"Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic","volume":"12","author":"Elfstr\u00f6m","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jcv.2024.105734_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107096","article-title":"Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders","volume":"160","author":"Ejegod","year":"2022","journal-title":"Prev. Med."},{"issue":"1","key":"10.1016\/j.jcv.2024.105734_bib0006","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.3747\/co.25.3915","article-title":"Self-collection for under-screened women in a National Cervical Screening Program: Pilot study","volume":"25","author":"Saville","year":"2018","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jcv.2024.105734_bib0007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands","volume":"125","author":"Polman","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.jcv.2024.105734_bib0008","unstructured":"Scottish cervical screening programme statistics - Annual update to 31 March 2022 - Scottish cervical screening programme statistics - Publications - Public Health Scotland. https:\/\/publichealthscotland.scot\/publications\/scottish-cervical-screening-programme-statistics\/scottish-cervical-screening-programme-statistics (last published 30 May 2023)."},{"issue":"2","key":"10.1016\/j.jcv.2024.105734_bib0009","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/08870446.2022.2050230","article-title":"Determinants of routine cervical screening participation in underserved women: A qualitative systematic review","volume":"39","author":"Wearn","year":"2024","journal-title":"Psychol. Health"},{"key":"10.1016\/j.jcv.2024.105734_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010660","article-title":"Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)","volume":"6","author":"Stanczuk","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcv.2024.105734_bib0011","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ijc.33888","article-title":"Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study","volume":"150","author":"Stanczuk","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2024.105734_bib0012","article-title":"The impact of offering multiple cervical screening options to women whose screening was overdue in Dumfries and Galloway, Scotland","volume":"29","author":"Wedisinghe","year":"2022","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.jcv.2024.105734_bib0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jviromet.2019.04.015","article-title":"Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay","volume":"270","author":"Borgfeldt","year":"2019","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2024.105734_bib0014","series-title":"Cervical screening: Professional Guidance","year":"2024"},{"key":"10.1016\/j.jcv.2024.105734_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13027-020-00280-0","article-title":"Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection","volume":"15","author":"Ernstson","year":"2020","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.jcv.2024.105734_bib0016","first-page":"1","article-title":"HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial","author":"Aasb\u00f8","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jcv.2024.105734_bib0017","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/09691413211052499","article-title":"Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia","volume":"29","author":"Veerus","year":"2022","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.jcv.2024.105734_bib0018","author":"rates in Scotland","year":"2024","journal-title":"Personal Communication, National Services Scotland, 28"},{"key":"10.1016\/j.jcv.2024.105734_bib0019","doi-asserted-by":"crossref","first-page":"102672","DOI":"10.1016\/j.eclinm.2024.102672","article-title":"Opportunistic offering of self-sampling to non-attenders within the English cervical screening programme: a pragmatic, multicentre, implementation feasibility trial with randomly allocated cluster intervention start dates (YouScreen)","volume":"73","author":"Lim","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jcv.2024.105734_bib0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/OLQ.0000000000000125","article-title":"Evaluation of a new APTIMA specimen collection and transportation kit for high-risk human papillomavirus E6\/E7 messenger RNA in cervical and vaginal samples","volume":"41","author":"Chernesky","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jcv.2024.105734_bib0021","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ijgo.12628","article-title":"High-risk HPV-RNA screening of physician- and self-collected specimens for detection of cervical lesions among female sex workers in Nairobi, Kenya","volume":"143","author":"Senkomago","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.jcv.2024.105734_bib0022","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/ijc.34170","article-title":"Human papillomavirus self-sampling with mRNA testing benefits routine screening","volume":"151","author":"Auvinen","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2024.105734_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2018.02.002","article-title":"Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples","volume":"101","author":"Asciutto","year":"2018","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.jcv.2024.105734_bib0024","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CEJ.0000000000000693","article-title":"Equal prevalence of severe cervical dysplasia by HPV self-sampling and by midwife-collected samples for primary HPV screening: A randomised controlled trial","volume":"30","author":"Hellsten","year":"2021","journal-title":"Eur. J. Cancer Prev."},{"issue":"7","key":"10.1016\/j.jcv.2024.105734_bib0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","article-title":"Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: A systematic review and meta- analysis","volume":"23","author":"Arbyn","year":"2022","journal-title":"Lancet Oncol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:39:28Z","timestamp":1732768768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653224000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"alternative-id":["S1386653224000969"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105734","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-risk HPV mRNA testing on self-samples offered to those who do not attend for organised cervical screening \u2013 real world data from the Dumfries and Galloway region in Scotland","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105734"}}